Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: Apr 29, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financial-statements
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics filed an 8-K on 4/29/25 with financial statements.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on April 29, 2025, reporting information under Regulation FD and including financial statements and exhibits. The company, formerly known as Atrinsic, Inc., MPLC, Inc., and NEW MOTION, INC., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates routine corporate reporting, including financial statements and exhibits, which provides transparency to investors about the company's current status.
Risk Assessment
Risk Level: low — This filing is a standard 8-K report and does not appear to contain any material adverse news or significant events.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- Atrinsic, Inc. (company) — Former company name
- NEW MOTION, INC. (company) — Former company name
- MPLC, Inc. (company) — Former company name
- April 29, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report information under Regulation FD and to include financial statements and exhibits.
What is the exact name of the company filing this report?
The exact name of the company is Protagenic Therapeutics, Inc.
In which state is Protagenic Therapeutics, Inc. incorporated?
Protagenic Therapeutics, Inc. is incorporated in Delaware.
What are some of the former names of Protagenic Therapeutics, Inc.?
Some of the former names of Protagenic Therapeutics, Inc. include Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
What is the SEC file number for Protagenic Therapeutics, Inc.?
The SEC file number for Protagenic Therapeutics, Inc. is 001-12555.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).